Cardinal Capital Management Inc (Canada)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,050
| Closed | -$641K | – | 54 |
|
|
2023
Q3 | $641K | Sell |
11,050
-100
| -0.9% | -$5.8K | 0.03% | 47 |
|
|
2023
Q2 | $713K | Sell |
11,150
-1,150
| -9% | -$73.5K | 0.04% | 46 |
|
|
2023
Q1 | $853K | Hold |
12,300
| – | – | 0.05% | 44 |
|
|
2022
Q4 | $885K | Sell |
12,300
-400
| -3% | -$28.8K | 0.05% | 46 |
|
|
2022
Q3 | $903K | Hold |
12,700
| – | – | 0.06% | 45 |
|
|
2022
Q2 | $978K | Hold |
12,700
| – | – | 0.05% | 46 |
|
|
2022
Q1 | $927K | Sell |
12,700
-400
| -3% | -$29.2K | 0.05% | 47 |
|
|
2021
Q4 | $817K | Hold |
13,100
| – | – | 0.04% | 49 |
|
|
2021
Q3 | $775K | Hold |
13,100
| – | – | 0.04% | 47 |
|
|
2021
Q2 | $875K | Buy |
13,100
+50
| +0.4% | +$3.34K | 0.05% | 47 |
|
|
2021
Q1 | $824K | Sell |
13,050
-1,000
| -7% | -$63.1K | 0.05% | 47 |
|
|
2020
Q4 | $872K | Hold |
14,050
| – | – | 0.05% | 50 |
|
|
2020
Q3 | $847K | Buy |
14,050
+200
| +1% | +$12.1K | 0.06% | 49 |
|
|
2020
Q2 | $814K | Hold |
13,850
| – | – | 0.07% | 44 |
|
|
2020
Q1 | $772K | Hold |
13,850
| – | – | 0.06% | 43 |
|
|
2019
Q4 | $889K | Buy |
13,850
+750
| +6% | +$48.1K | 0.06% | 46 |
|
|
2019
Q3 | $664K | Buy |
13,100
+300
| +2% | +$15.2K | 0.06% | 39 |
|
|
2019
Q2 | $580K | Buy |
12,800
+200
| +2% | +$9.06K | 0.06% | 38 |
|
|
2019
Q1 | $601K | Buy |
12,600
+200
| +2% | +$9.54K | 0.06% | 40 |
|
|
2018
Q4 | $645K | Buy |
12,400
+800
| +7% | +$41.6K | 0.08% | 37 |
|
|
2018
Q3 | $720K | Hold |
11,600
| – | – | 0.07% | 44 |
|
|
2018
Q2 | $642K | Buy |
+11,600
| New | +$642K | 0.06% | 44 |
|